AstraZeneca Rare Disease seeks a Global Strategy Lead to develop and manage commercial strategies for the Hypophosphatasia portfolio across top 21 markets. This role leads global brand strategy, pre-launch planning, and business performance in a matrix environment with accountability for portfolio commercialization.
Responsibilities
- Lead Value Sub Team to refine and safeguard strategic value propositions based on market and clinical outcomes
- Develop Disease Strategy Plan and drive commercial strategy alignment across integral and regional markets
- Drive pre-launch strategy and planning 12-18 months prior to launch with cross-functional partners
- Develop long-range global forecasts and commercial positioning for portfolio brands
- Provide regular strategic updates and business performance reports to senior leadership





Requirements
- Bachelor's degree in business or life sciences; Master's degree preferred
- 10+ years pharmaceutical or biotech industry experience with pre-launch and launch planning
- Country-level or above-country leadership experience with P&L; responsibility in major healthcare markets
- Broad marketing and commercial experience across brand lifecycle stages
- Deep understanding of rare disease drug development and commercialization
- Proven ability to collaborate across matrix teams and stakeholder groups
- Knowledge of pharmaceutical compliance regulations and pharmacovigilance

📌 Global Strategy Lead, Rare Bone and Endocrine Disorders (España)
🏢 AstraZeneca
📍 España